Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 847368, 9 pages
http://dx.doi.org/10.1155/2014/847368
Research Article

The Neuroprotective Effect of Cornus mas on Brain Tissue of Wistar Rats

1Department of Bioorganic Chemistry, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland
2State Higher Vocational School, Institute of Health, Staszica 1 Street, 33-300 Nowy Sacz, Poland
3Department of Food Chemistry and Nutrition, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Krakow, Poland
4Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Yuzuncu Yıl University, Zeve Campus, 65080 Van, Turkey
5Department of Mechanical Engineering and Agrophysics, Faculty of Production Engineering and Energetics, University of Agriculture in Krakow, 116 B Balicka Street, 30-149 Krakow, Poland

Received 7 January 2014; Revised 11 July 2014; Accepted 23 July 2014; Published 16 October 2014

Academic Editor: João B. T. Da Rocha

Copyright © 2014 Renata Francik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Tural and I. Koca, “Physico-chemical and antioxidant properties of cornelian cherry fruits (Cornus mas L.) grown in Turkey,” Scientia Horticulturae, vol. 116, no. 4, pp. 362–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. E. W. Askew, “Environmental and physical stress and nutrient requirements,” The American Journal of Clinical Nutrition, vol. 61, no. 3, pp. 631S–637S, 1995. View at Google Scholar · View at Scopus
  3. Z. Zadak, R. Hyspler, A. Ticha et al., “Antioxidants and vitamins in clinical conditions,” Physiological Research, vol. 58, pp. S13–S17, 2009. View at Google Scholar
  4. J. S. A. Edwards, E. W. Askew, N. King, and C. J. Fulco, “Nutritional intake and carbohydrate supplementation at high altitude,” Journal of Wilderness Medicine, vol. 158, pp. 458–465, 1994. View at Google Scholar · View at Scopus
  5. R. de la Puerta, A. Marquez-Martin, A. Fernandez-Arche, and V. Ruiz-Gutierrez, “Influence of dietary fat on oxidative stress and inflammation in murine macrophages,” Nutrition, vol. 25, no. 5, pp. 548–554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Krośniak, M. Ga̧sto, M. Szałkowski, P. Zagrodzki, and M. Derwisz, “Cornelian cherry (Cornus mas L.) juices as a source of minerals in human diet,” Journal of Toxicology and Environmental Health A: Current Issues, vol. 73, no. 17-18, pp. 1155–1158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Dalpiaz, B. Pavan, S. Vertuani et al., “Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs,” European Journal of Pharmaceutical Sciences, vol. 24, no. 4, pp. 259–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Gordon and R. W. Newton, “Glucose transporter type1 (GLUT-1) deficiency,” Brain and Development, vol. 25, no. 7, pp. 477–480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Santos, A. R. Tomé, R. Saldanha et al., “Oxidative stress in the hippocampus during experimental seizures can be ameliorated with the antioxidant ascorbic acid,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 4, pp. 214–221, 2009. View at Publisher · View at Google Scholar
  10. S. K. Vareed, M. K. Reddy, R. E. Schutzki, and M. G. Nair, “Anthocyanins in Cornus alternifolia, Cornus controversa, Cornus kousa and Cornus florida fruits with health benefits,” Life Sciences, vol. 78, no. 7, pp. 777–784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Y. Sun and G. Y. Sun, “Ethanol and oxidative mechanisms in the brain,” Journal of Biomedical Science, vol. 8, no. 1, pp. 37–43, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Han, W. Zheng, S. Bastianetto, J. Chabot, and R. Quirion, “Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C,” British Journal of Pharmacology, vol. 141, no. 6, pp. 997–1005, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. K. Gupta, S. Briyal, and G. Chaudhary, “Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats,” Pharmacology Biochemistry and Behavior, vol. 71, no. 1-2, pp. 245–249, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Wang, S. Yu, A. Simonyi, G. Rottinghaus, G. Y. Sun, and A. Y. Sun, “Resveratrol protects against neurotoxicity induced by kainic acid,” Neurochemical Research, vol. 29, no. 11, pp. 2105–2112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. N. T. Zaveri, “Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications,” Life Sciences, vol. 78, no. 18, pp. 2073–2080, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Xie, W. Wang, Z. Mao et al., “Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats,” Neuroscience Letters, vol. 516, no. 2, pp. 237–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Yang, G. P. Lim, A. N. Begum et al., “Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo,” Journal of Biological Chemistry, vol. 280, no. 7, pp. 5892–5901, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. H. J. Shin, J. Y. Lee, E. Son et al., “Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice,” Neuroscience Letters, vol. 416, no. 1, pp. 49–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Mehla, K. H. Reeta, P. Gupta, and Y. K. Gupta, “Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model,” Life Sciences, vol. 87, no. 19–22, pp. 596–603, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Golechha, J. Bhatia, and D. S. Arya, “Hydroalcoholic extract of Emblica officinalis Gaertn. affords protection against PTZ-induced seizures, oxidative stress and cognitive impairment in rats,” Indian Journal of Experimental Biology, vol. 48, no. 5, pp. 474–478, 2010. View at Google Scholar · View at Scopus
  21. B. Chowdhury, S. K. Bhattamisra, and M. C. Das, “Anti-convulsant action and amelioration of oxidative stress by Glycyrrhiza glabra root extract in pentylenetetrazole-induced seizure in albino rats,” Indian Journal of Pharmacology, vol. 45, no. 1, pp. 40–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. V. Obolentseva, V. I. Litvinenko, A. S. Ammosov, T. P. Popova, and A. M. Sampiev, “Pharmacological and therapeutic properties of licorice preparations,” Pharmaceutical Chemistry Journal, vol. 33, no. 8, pp. 427–434, 1999. View at Google Scholar · View at Scopus
  23. Y. Chuang, “Mitochondrial dysfunction and oxidative stress in seizure-induced neuronal cell death,” Acta Neurologica Taiwanica, vol. 19, no. 1, pp. 3–15, 2010. View at Google Scholar · View at Scopus
  24. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, no. C, pp. 121–126, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. H. W. Eckerson, J. Romson, C. Wyte, and B. N. La Du, “The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts,” The American Journal of Human Genetics, vol. 35, no. 2, pp. 214–227, 1983. View at Google Scholar · View at Scopus
  26. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. R. L. Levine, D. Garland, C. N. Oliver et al., “Determination of carbonyl content in oxidatively modified proteins,” Methods in Enzymology, vol. 186, pp. 464–478, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. M. L. Hu, “Measurement of protein thiol groups and glutathione in plasma,” Methods in Enzymology, vol. 233, pp. 380–385, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Sun, J. Zhang, X. Lu, L. Zhang, and Y. Zhang, “Evaluation to the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves,” Food and Chemical Toxicology, vol. 49, no. 10, pp. 2689–2696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. K. Willcox, S. L. Ash, and G. L. Catignani, “Antioxidants and prevention of chronic disease,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 4, pp. 275–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Tsuda, F. Horio, and T. Osawa, “The role of anthocyanins as an antioxidant under oxidative stress in rats,” BioFactors, vol. 13, no. 1–4, pp. 133–139, 2000. View at Google Scholar · View at Scopus
  32. M. Ga̧stoł, M. Krośniak, M. Derwisz, and J. Dobrowolska-Iwanek, “Cornelian cherry (Cornus mas L.) juice as a potential source of biological compounds,” Journal of Medicinal Food, vol. 16, no. 8, pp. 728–732, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. X. Xu and S. F. Lee, “Activity of plant flavonoids against antibiotic-resistant bacteria,” Phytotherapy Research, vol. 15, pp. 39–43, 2001. View at Publisher · View at Google Scholar
  34. H. Fumie and H. Hidenori, “Significance of catalase in peroxisomal fatty acyl-CoA β-oxidation,” Biochimica et Biophysica Acta, vol. 921, no. 1, pp. 142–150, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. S. M. Zimatkin and K. O. Lindros, “Distribution of catalase in rat brain: aminergic neurons as possible targets for ethanol effects,” Alcohol and Alcoholism, vol. 31, no. 2, pp. 167–174, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Zielaskowska and D. Olszewska-Słonina, “The polymorphism of paraoxonase and its effects in physiological and pathological processes,” Advances in Clinical and Experimental Medicine, vol. 15, no. 6, pp. 1073–1078, 2006. View at Google Scholar · View at Scopus
  37. B. Sapian-Raczkowska, M. Rabczyński, and R. Adamiec, “Paraoksonaza—wazny enzym przemian lipidowych i potencjalny sprzymierzeniec w leczeniu,” Polski Merkuriusz Lekarski, vol. 173, pp. 325–331, 2010. View at Google Scholar
  38. R. S. Birjmohun, M. Vergeer, E. S. G. Stroes et al., “Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk prospective population study,” PLoS ONE, vol. 4, no. 8, Article ID e6809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Ünsal, Y. Albayrak, N. Albayrak, M. Kuloğlu, and K. Hashimoto, “Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine,” Neuropsychiatric Disease and Treatment, vol. 9, pp. 1545–1552, 2013. View at Publisher · View at Google Scholar
  40. L. S. Rozek, T. S. Hatsukami, R. J. Richter et al., “The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status,” Journal of Lipid Research, vol. 46, no. 9, pp. 1888–1895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Zago, S. Sanguinetti, F. Brites et al., “Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women,” Atherosclerosis, vol. 177, no. 1, pp. 203–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. G. P. Jarvik, N. T. Tsai, L. A. McKinstry et al., “Vitamin C and E intake is associated with increased paraoxonase activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 8, pp. 1329–1333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Ozyurt, B. Demirata, and R. Apak, “Determination of total antioxidant capacity by a new spectrophotometric method based on Ce(IV) reducing capacity measurement,” Talanta, vol. 71, no. 3, pp. 1155–1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. C. Andreazza, L. Shoo, J. Wang, and L. Trevor Young, “Mitochondrial complex i activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder,” Archives of General Psychiatry, vol. 67, no. 4, pp. 360–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Castegna, M. Aksenov, M. Aksenova et al., “Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I. Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1,” Free Radical Biology and Medicine, vol. 33, no. 4, pp. 562–571, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Dalle-Donne, G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani, “Protein carbonylation, cellular dysfunction, and disease progression,” Journal of Cellular and Molecular Medicine, vol. 10, no. 2, pp. 389–406, 2006. View at Publisher · View at Google Scholar · View at Scopus